Project Details
Project Description
GPCRs are the most important class of receptors in the human genome and are involved in virtually all
physiological processes. They are key players in the major health burdens of the 21st century, including
mental illness, obesity & diabetes, cardiovascular disease, cancer and inflammation. This project seeks to
gain a more detailed fundamental understanding of the mechanisms of GPCR function by small molecule
ligands. More specifically, our research will address two novel and exciting biological paradigms that have
emerged in recent years, GPCR allosteric modulation and functional selectivity, and provide novel chemical
tools and optimized biological assays for detecting and quantifying these phenomena
physiological processes. They are key players in the major health burdens of the 21st century, including
mental illness, obesity & diabetes, cardiovascular disease, cancer and inflammation. This project seeks to
gain a more detailed fundamental understanding of the mechanisms of GPCR function by small molecule
ligands. More specifically, our research will address two novel and exciting biological paradigms that have
emerged in recent years, GPCR allosteric modulation and functional selectivity, and provide novel chemical
tools and optimized biological assays for detecting and quantifying these phenomena
| Status | Finished |
|---|---|
| Effective start/end date | 4/01/11 → 31/12/14 |
Funding
- ARC - Australian Research Council: A$420,000.00
- Monash University
Research output
- 8 Article
-
Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and Efficacy
Wakeham, M. C. L., Davie, B. J., Chalmers, D. K., Christopoulos, A., Capuano, B., Valant, C. & Scammells, P. J., 5 Jan 2022, In: ACS Chemical Neuroscience. 13, 1, p. 97-111 15 p.Research output: Contribution to journal › Article › Research › peer-review
5 Link opens in a new tab Citations (Scopus) -
Development of Novel 4-Arylpyridin-2-one and 6-Arylpyrimidin-4-one Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor
Jörg, M., Khajehali, E., van der Westhuizen, E. T., C. Choy, K. H., Shackleford, D. M., Tobin, A. B., Sexton, P. M., Valant, C., Capuano, B., Christopoulos, A. & Scammells, P. J., 8 Jan 2021, In: ChemMedChem. 16, 1, p. 216-233 18 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access6 Link opens in a new tab Citations (Scopus) -
Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory Profiles
Dallagnol, J. C. C., Khajehali, E., Van Der Westhuizen, E. T., Jörg, M., Valant, C., Gonçalves, A. G., Capuano, B., Christopoulos, A. & Scammells, P. J., 12 Apr 2018, In: Journal of Medicinal Chemistry. 61, 7, p. 2875-2894 20 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile17 Link opens in a new tab Citations (Scopus)